Syria’s rebel-held northwest will
receive its first shipment of AstraZeneca’s coronavirus vaccine by the end of
next month, the World Health Organization said Tuesday.
The doses were procured through the UN body’s Covax programme, which aims
to provide equitable worldwide access to vaccines against Covid-19.
Thirty-five to 40 percent of the vaccines would be made available in the
first quarter of 2021, and 60 to 65 percent in the second quarter, a WHO
spokesperson told AFP.
The health directorate for the opposition-held territory said it expected
to receive 120,000 doses of the AstraZeneca vaccine by next month.
“They will cover 60,000 people,” starting with front-line health workers,
the elderly and chronically ill people, said its spokesman Imad Zahran.
Syria’s northwest, much of which is controlled by Hayat Tahrir al-Sham, is
home to some four million people, including 2.8 million in need of urgent
HTS is an alliance dominated by ex-members of Syria’s former Al-Qaeda
Rights groups fear crowded displacement camps in the area could be
especially conducive to a critical coronavirus outbreak.
The rebel stronghold has reported 21,136 infections and 408 fatalities
since its outbreak began last year.
In government-held areas of Syria, authorities have recorded 15,230
coronavirus infections and 1,001 fatalities.
Territories under Kurdish control in the country’s northeast have recorded
nearly 8,600 cases and 313 deaths.
But doctors and rights organisations believe the numbers are probably much
higher, especially in northeast Syria where rights groups say the government
has refused to allow the UN to set up Covid testing labs.
An official with the Kurdish administration in northeast Syria said they
were “in talks with the WHO for the procurement of the coronavirus vaccine
but have yet to clinch a deal”.
In December, the government in Damascus submitted a request to join WHO’s
Covax initiative and in January it said it had officially signed on.
The WHO, together with the UN children’s agency UNICEF and Gavi, said they
would support Syria in acquiring jabs to initially cover at least three
percent of the population and aim for 20 percent by the end of the year.
Syria has also authorised the use of Russia’s Sputnik V coronavirus
vaccine, its embassy in Moscow said Monday.
Human Rights Watch this month urged support for aid groups to ensure
“equitable” distribution of coronavirus vaccines across all of war-torn
Syria, warning against any discriminatory approach by Damascus.
Source: Bangladesh Sangbad Sangstha (BSS)